July 23, 2026
Scientists Move Closer to Creating Human Sperm in the Lab
Researchers successfully generated immature human sperm precursor cells using engineered blood cells, marking a major advance in fertility…

By Faisal Khan
4 min read
- 1 ARTIFICIAL SPERM
- 2 Researchers successfully generated immature human sperm precursor cells using engineered blood cells, marking a major advance in fertility science
- 3 Reprogramming Blood Cells into the Earliest Stages of Sperm
- 4 Growing Human Reproductive Cells Inside Living Tissue
- 5 Why Mature Human Sperm Remains Out of Reach
ARTIFICIAL SPERM
Researchers successfully generated immature human sperm precursor cells using engineered blood cells, marking a major advance in fertility science
The idea of creating human sperm in a laboratory once belonged firmly in the realm of science fiction. The concept of taking a person's blood cells, reprogramming them into stem cells, and ultimately transforming them into sperm capable of creating life seemed decades away from reality. Yet science has taken another remarkable step toward that future.
In a groundbreaking study, researchers have demonstrated that human blood-derived cells can be engineered into immature sperm precursor cells when transplanted into a specialized environment grown on a mouse kidney. Although the cells stopped short of becoming fully mature sperm, the achievement represents one of the most significant advances yet in understanding human reproductive biology.
The research opens exciting possibilities for treating infertility and deepening our understanding of early human development. At the same time, it revives profound ethical debates surrounding reproductive technologies, genetic engineering, and the future of assisted reproduction.
Reprogramming Blood Cells into the Earliest Stages of Sperm
The study, led by researchers including Katsuhiko Hayashi and Mitinori Saitou's collaborators such as Ryosuke Sasaki and colleagues, builds upon more than a decade of advances in induced pluripotent stem (iPS) cell technology. Induced pluripotent stem cells are adult cells, often collected from blood or skin, that are genetically reprogrammed to behave like embryonic stem cells.
Once "reset," these versatile cells can potentially develop into nearly any tissue in the human body. In previous years, scientists successfully used this approach in mice, producing functional eggs and sperm from skin cells. In one remarkable experiment, researchers even created healthy offspring using reproductive cells generated from two male mice, demonstrating the extraordinary potential of cellular reprogramming.
However, translating these achievements from rodents to humans has proven far more difficult. Human reproductive development follows a much more complex biological timeline, and ethical limitations prevent direct experimentation on early human embryos, leaving scientists with limited opportunities to observe the earliest stages of sperm formation.
Growing Human Reproductive Cells Inside Living Tissue
To overcome this challenge, the research team adopted an innovative strategy. Instead of attempting to mature sperm entirely inside laboratory dishes, they transplanted human stem-cell-derived reproductive precursor cells into a small pouch created on the kidneys of laboratory mice. The kidney provides an ideal environment for transplanted tissues because of its rich blood supply and stable physiological conditions.
Over approximately six months, something remarkable happened. The transplanted human cells self-organized into structures resembling seminiferous tubules — the microscopic tubes inside human testes where sperm normally develop. Within these structures, the cells matured into spermatogonia, the earliest recognizable sperm-producing cells.
Detailed genetic analysis revealed that these laboratory-generated spermatogonia exhibited gene expression patterns remarkably similar to those found in naturally developing human reproductive tissue. In other words, the researchers had successfully recreated one of the earliest stages of human sperm production outside the human body.
Why Mature Human Sperm Remains Out of Reach
Despite this impressive achievement, the study stopped short of its ultimate objective. The spermatogonia failed to continue their developmental journey into fully mature sperm capable of fertilization. The researchers encountered the same developmental barrier when repeating similar experiments using macaques, suggesting that the challenge reflects fundamental biological complexities shared among primates rather than a flaw unique to the human experiments.
Scientists still do not fully understand the intricate molecular signals, hormonal interactions, and structural environments required for complete sperm maturation in humans. Without that knowledge, recreating the entire developmental process remains extraordinarily difficult.
The next major scientific question is whether these laboratory-generated spermatogonia are functionally equivalent to naturally occurring ones. Direct testing in humans would cross widely accepted ethical boundaries, so researchers hope to investigate this question using non-human primate models.
A Potential Revolution in Infertility Treatment
If future research eventually succeeds in producing fully functional sperm, the medical implications could be transformative. Millions of couples worldwide experience infertility, with male reproductive disorders contributing to approximately half of infertility cases.
Laboratory-generated sperm could potentially help individuals who cannot naturally produce viable reproductive cells due to genetic disorders, cancer treatments, developmental abnormalities, or certain medical conditions. Beyond infertility treatment, the technology could dramatically improve scientists' understanding of male reproductive disorders, allowing researchers to study diseases affecting fertility without relying solely on limited human tissue samples.
The ability to observe sperm development in real time could also accelerate discoveries about genetic diseases, developmental disorders, and reproductive health.
The Ethical Questions Cannot Be Ignored
With every major advance in reproductive biotechnology comes an equally significant ethical discussion. Perhaps the most controversial possibility is using laboratory-generated sperm, or eventually eggs, to create human embryos. Some bioethicists worry that the technology could lower barriers to germline genetic engineering, making it easier to modify reproductive cells before conception.
Although gene-editing tools such as CRISPR already exist, combining them with laboratory-produced reproductive cells could increase concerns about "designer babies," where genetic traits are intentionally selected or modified beyond treating disease. Additional questions arise regarding consent, parenthood, regulation, and long-term safety.
If reproductive cells can be generated from ordinary blood or skin samples, who controls those cells? What safeguards should govern their use? How should society distinguish between legitimate medical treatments and human enhancement? These questions extend far beyond biology into law, ethics, public policy, and philosophy.
A Carefully Measured Scientific Breakthrough
It is important to recognize that this research does not represent the creation of laboratory-made human sperm. Rather, it marks a substantial advance toward understanding one of biology's most complex developmental processes. By successfully generating human spermatogonia within living tissue, researchers have crossed a scientific milestone that many believed would remain out of reach for years.
Whether this work eventually leads to new infertility therapies or remains primarily a tool for studying human development, it significantly expands our knowledge of reproductive biology. As with many transformative discoveries, the science is advancing faster than society can answer the ethical questions it raises.
The challenge over the coming decades will not simply be determining whether scientists can create fully functional human sperm in the laboratory, but deciding under what circumstances they should. Complete research was published in the Journal of Cell Stem Cell.
Originally published at https://khanfk.substack.com on July 23, 2026.